⌘K

Login Start Free

Home/Filings/4/0001323885-23-000112

4//SEC Filing

Dahlquist Karl S. 4

Accession 0001323885-23-000112

CIK 0001323885other

View on SEC.gov Company Profile

Filed

Nov 2, 8:00 PM ET

Accepted

Nov 3, 8:40 AM ET

Size

4.5 KB

Accession

0001323885-23-000112

Insider Transaction Report

Form 4

Period: 2023-11-01

AtriCure, Inc.ATRC

Dahlquist Karl S.

Chief Legal Officer

Transactions

Sale
Common Stock
2023-11-01$34.43/sh−1,248$42,969→ 30,789 total

Footnotes (1)

[F1]These shares were sold pursuant to a 10b5-1 trading plan adopted on February 24, 2023.

Documents

1 file

4
wk-form4_1699015194.xmlPrimary
FORM 4

Issuer

AtriCure, Inc.

CIK 0001323885

Entity typeother

Related Parties

1

filerCIK 0001861996

Filing Metadata

Form type: 4
Filed: Nov 2, 8:00 PM ET
Accepted: Nov 3, 8:40 AM ET
Size: 4.5 KB

View on SEC.gov